For Patients

?

Placeholder text (you can add a block title above)

For Patients

Across multiple tumor types, the majority of patients with cancer are likely to face treatment resistance as some point. OncoGenex is committed to exploring new compounds to meet the challenge of cancer treatment resistance and to the development and commercialization of innovative therapies that have the potential to redefine treatment outcomes for patients with a variety of cancers.

We are currently evaluating two drugs for the treatment of prostate, bladder, lung, and pancreatic cancers.

External Link Pop Up Window

You are now exiting the OncoGenex Web site and entering a third party Web site.

OncoGenex does not review the information contained on the following Web site for content, accuracy or completeness. Use of and access to the information are subject to the terms, limitations and conditions set by the Web site producer. OncoGenex makes no claims about the accuracy or any other aspect of the information contained on this Web site, nor does OncoGenex necessarily endorse this Web site.

Stay on OncoGenex Continue